AKT3 and diabetic kidney disease: Our study found that circ‐AKT3 suppressed the extracellular matrix accumulation in diabetic nephropathy mesangial cells via regulating miR‐296‐3p/E‐cadherin signals, which may provide a possible biomarker for the diagnosis and treatment of diabetic nephropathy.